Jin Suk Kang

413 citations
34 papers · 273 indexed · h-index 10
Topics
Viral-associated cancers and disorders (4 papers)HIV/AIDS drug development and treatment (4 papers)Urinary Tract Infections Management (4 papers)

In The Last Decade

Jin Suk Kang

32 papers receiving 266 citations

Peers

Jin Suk Kang
Comparison fields: 5 of 70
  • Epidemiology 82
  • Molecular Medicine 52
  • Infectious Diseases 46
  • Surgery 43
  • Pharmacology 30
Replace Radu-Ştefan Miftode with:
Radu-Ştefan Miftode Romania
Ionela-Larisa Miftode Romania
Sina Helbig Germany
Dalia Adukauskienė Lithuania
Selvi Kelekçi Türkiye
Małgorzata Mikaszewska-Sokolewicz Poland
Т С Перепанова Russia
Mehrdad Haghighi Iran
Robert Sinto Indonesia
Masahiro Yasuda Japan
Jin Suk Kang relative to Radu-Ştefan Miftode Romania Radu-Ştefan Miftode's profile →
Citations per field
00.5×10×15×20×
Radu-Ştefan Miftode · 1×
Citations per year

Countries citing papers authored by Jin Suk Kang

Since Specialization
Citations

This map shows the geographic impact of Jin Suk Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Suk Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Suk Kang more than expected).

Fields of papers citing papers by Jin Suk Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Suk Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Suk Kang. The network helps show where Jin Suk Kang may publish in the future.

Co-authorship network of co-authors of Jin Suk Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Suk Kang. A scholar is included among the top collaborators of Jin Suk Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Suk Kang. Jin Suk Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 1
4 3
5 3
6 11
7 4
8 4
9 4
10 18
11 1
12 3
13 45
14 9
15 24
16 6
17 7
18 32
19 2
20 19

About Jin Suk Kang

Jin Suk Kang is a scholar working on Virology, Molecular Medicine and Infectious Diseases, having authored 34 papers that have together received 273 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (4 papers), HIV/AIDS drug development and treatment (4 papers) and Urinary Tract Infections Management (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (29 citations), Molecular Medicine (52 citations) and Endocrinology (21 citations). Jin Suk Kang has collaborated with scholars based in South Korea, United States and Taiwan. Frequent co-authors include Jeong Eun Lee, Kye‐Hyung Kim, Shinwon Lee, Sun Hee Lee, Jongyoun Yi, Ihm Soo Kwak, Ewa Rajpert‐De Meyts, Joëlle Wiels, Soo Bong Lee and Eun Young Seong. Their work appears in journals such as PLoS ONE, Scientific Reports and Drug and Alcohol Dependence.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026